CS logo
small CS logo
Krankenhaus Hietzing, 2. Medizinische Abteilung

Wien, Austria
Hospital in Vienna
Wolkersbergenstraße 1, 1130 Wien

About Krankenhaus Hietzing, 2. Medizinische Abteilung


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Josef Smolen, Univ. Prof. Dr.
1
Medical University of Vienna
1
Total Rows: 2

Clinical Trials at Krankenhaus Hietzing, 2. Medizinische Abteilung


During the past decade, Krankenhaus Hietzing, 2. Medizinische Abteilung conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11110000Started TrialsCompleted Trails2017201800.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)
2017-11-24
2020-06-02
Completed
39
A Study to Target the Type I IFN Receptor by Administrating Anifrolumab in RA Patients With a High IFN Signature (TarIFNiRA)
2018-04-18
2021-03-01
Unknown status
24

Rows per page:

1–2 of 2

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsJosef Smolen, Univ. Prof. Dr.: 1Josef Smolen, Univ. Prof. Dr.: 1Medical University of Vienna: 1Medical University of Vienna: 1

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Krankenhaus Hietzing, 2. Medizinische Abteilung


According to Clinical.Site data, the most researched conditions in "Krankenhaus Hietzing, 2. Medizinische Abteilung" are "Polymyalgia Rheumatica" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Krankenhaus Hietzing, 2. Medizinische Abteilung" in a lesser frequency.

Clinical Trials Intervention Types at Krankenhaus Hietzing, 2. Medizinische Abteilung


Most popular intervention types in "Krankenhaus Hietzing, 2. Medizinische Abteilung" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebos" (2 trials), "Anifrolumab" (1 trials), "Glucocorticoids" (1 trials) and "Tocilizumab Prefilled Syringe [Actemra]" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Krankenhaus Hietzing, 2. Medizinische Abteilung


The vast majority of trials in "Krankenhaus Hietzing, 2. Medizinische Abteilung" are 2 trials for "All" genders.

Clinical Trials Status at Krankenhaus Hietzing, 2. Medizinische Abteilung


Currently, there are NaN active trials in "Krankenhaus Hietzing, 2. Medizinische Abteilung". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Krankenhaus Hietzing, 2. Medizinische Abteilung, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Krankenhaus Hietzing, 2. Medizinische Abteilung, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 1Phase 2: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 1Completed: 1Unknown status: 1Unknown status: 1